Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

Abstract Background Glucocorticoid treatment remains the cornerstone of therapy for immune checkpoint inhibitor (ICI) myocarditis, but data supporting the use of additional immunotherapy for steroid refractory cases remains limited. We investigate the safety and efficacy of infliximab in patients wi...

Full description

Bibliographic Details
Main Authors: Robert S. Zhang, Allison Padegimas, Kathleen M. Murphy, Peter T. Evans, Carli J. Peters, Christopher M. Domenico, Mahesh K. Vidula, Paul J. Mather, Marisa Cevasco, Roger B. Cohen, Joseph R. Carver, Rupal P. O’Quinn
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Cardio-Oncology
Subjects:
Immune checkpoint inhibitor
Myocarditis
Infliximab
Cardio‐oncology
Pembrolizumab
Nivolumab
Online Access:https://doi.org/10.1186/s40959-021-00095-x

Internet

https://doi.org/10.1186/s40959-021-00095-x

Similar Items